Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase.

Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, van Swam II, Kleerebezem M, Salvador-Cartier C, Hisbergues M, Bueno L, Theodorou V, Fioramonti J.

Inflamm Bowel Dis. 2006 Nov;12(11):1044-52.

PMID:
17075345
2.

A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.

Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailón E, Nieto A, Concha A, Olivares M, Zarzuelo A, Xaus J, Gálvez J.

Br J Nutr. 2007 Jan;97(1):96-103.

PMID:
17217564
3.

Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats.

Lamine F, Eutamène H, Fioramonti J, Buéno L, Théodorou V.

Scand J Gastroenterol. 2004 Dec;39(12):1250-8.

PMID:
15743003
4.

A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.

Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J.

J Appl Microbiol. 2007 Oct;103(4):836-44.

PMID:
17897185
5.

Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats.

Lamine F, Fioramonti J, Bueno L, Nepveu F, Cauquil E, Lobysheva I, Eutamène H, Théodorou V.

Scand J Gastroenterol. 2004 Jan;39(1):37-45.

PMID:
14992560
6.

Effect of intracolonic benzalkonium chloride on trinitrobenzene sulphonic acid-induced colitis in the rat.

Miampamba M, Parr EJ, McCafferty DM, Wallace JL, Sharkey KA.

Aliment Pharmacol Ther. 1998 Mar;12(3):219-28.

PMID:
9570256
7.

Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis.

Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J.

Int J Colorectal Dis. 2006 Dec;21(8):737-46. Epub 2005 Jul 29.

PMID:
16052308
8.

Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.

Seguí J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, Coronel P, Piqué JM, Panés J.

J Leukoc Biol. 2004 Sep;76(3):537-44. Epub 2004 Jun 14.

PMID:
15197232
9.

Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis.

Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS.

Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G729-38. Epub 2007 Jul 19.

PMID:
17640978
10.

Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Foligné B, Nutten S, Steidler L, Dennin V, Goudercourt D, Mercenier A, Pot B.

Dig Dis Sci. 2006 Feb;51(2):390-400.

PMID:
16534687
11.

On the benefit of whey-cultured Lactobacillus casei in murine colitis.

Ghasemi-Niri SF, Abdolghaffari AH, Fallah-Benakohal S, Hosseinpour-Feizi M, Mahdaviani P, Jamalifar H, Baeeri M, Dehghan G, Abdollahi M.

J Physiol Pharmacol. 2011 Jun;62(3):341-6.

PMID:
21893695
12.

[The establishment of TNBS-induced experimental colitis].

Zhu F, Qian J, Pan G.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Aug;20(4):271-8. Chinese.

PMID:
11367691
13.

Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Diel P.

Eur J Nutr. 2009 Jun;48(4):213-20. doi: 10.1007/s00394-009-0004-3. Epub 2009 Feb 21.

PMID:
19234664
14.

Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.

Amit-Romach E, Uni Z, Reifen R.

Dis Colon Rectum. 2008 Dec;51(12):1828-36. doi: 10.1007/s10350-008-9394-1. Epub 2008 Jul 17.

PMID:
18633675
15.

Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.

Dudhgaonkar SP, Tandan SK, Kumar D, Raviprakash V, Kataria M.

Inflammopharmacology. 2007 Oct;15(5):188-95.

PMID:
17943250
16.

Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats.

Seo HG, Takata I, Nakamura M, Tatsumi H, Suzuki K, Fujii J, Taniguchi N.

Arch Biochem Biophys. 1995 Dec 1;324(1):41-7.

PMID:
7503557
17.

Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats.

Sengül N, Aslím B, Uçar G, Yücel N, Işik S, Bozkurt H, Sakaoğullari Z, Atalay F.

Dis Colon Rectum. 2006 Feb;49(2):250-8.

PMID:
16362802
18.

Probiotic therapy fails to improve gut permeability in a hapten model of colitis.

Kennedy RJ, Hoper M, Deodhar K, Kirk SJ, Gardiner KR.

Scand J Gastroenterol. 2000 Dec;35(12):1266-71.

PMID:
11199365
19.

Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats.

Moorthy G, Murali MR, Devaraj SN.

Nutrition. 2007 May;23(5):424-33.

PMID:
17483010
20.

Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.

Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C.

Gastroenterology. 2007 Sep;133(3):862-74. Epub 2007 Jun 20.

PMID:
17678918

Supplemental Content

Support Center